Current Investments
Current Investments

Solvias is a provider of analytical laboratory testing services to pharmaceutical, biotechnology, and medical device customers. Headquartered in the biotech hub of Basel, Switzerland, Solvias performs tests on products and production processes used in clinical drug development and commercial production, with a full service offering and expertise in critical capabilities such as method development, stability studies, raw material testing, and elemental impurities.

Market Opportunity: Analytical lab testing is a $5+ billion global market, as companies, regulators, and end-users seek to ensure that drugs are validated for quality, purity, and strength. Moreover, in recent years, Solvias has extended its services to address high-growth biologic products and emerging cell and gene therapies.

Scalable, High Quality Platform: Solvias is one of the largest independent pharmaceutical laboratory services platforms, serving more than 600 customers out of its nearly 200,000 square feet of laboratory space that conform with the highest industry standards, including ISO, cGMP and GLP. The company employs more than 550 highly qualified team members who deliver innovative solutions and are highly regarded for their scientific acumen, technical capabilities, and outstanding quality of work.

Numerous Opportunities to Add Value: Solvias partnered with JLL to advance its strategic expansion focused on building the company into a global leader in the industry. Together, we are committed to extending Solvias’s capabilities into new and complementary areas and expanding its international footprint, while also supporting investments in organizational talent, infrastructure, and operations as the company continues to scale.

Visit Solvias

INVESTMENT STRATEGY